| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/22/2004 | WO2003089906A3 Functionalized nanoparticles and methods of use |
| 01/22/2004 | WO2003089457A3 Peptide inhibitors of protein kinase c ϝ for pain management |
| 01/22/2004 | WO2003078656A3 Dna markers for cattle or beef products |
| 01/22/2004 | WO2003071252A3 Methods for analysis of molecular events |
| 01/22/2004 | WO2003067213A3 Modulation of sulfate permease for photosynthetic hydrogen production |
| 01/22/2004 | WO2003066897A3 Specific multiplex analysis of nucleic acids |
| 01/22/2004 | WO2003066882A3 Method and apparatus for validating dna sequences without sequencing |
| 01/22/2004 | WO2003062449A3 Methods of isolating specific cells of caenorhabditis elegans and obtaining genomic information therefrom |
| 01/22/2004 | WO2003060521A3 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 01/22/2004 | WO2003060159A3 Methods of nucleic acid amplification |
| 01/22/2004 | WO2003054213A3 Non-human primate fc receptors and methods of use |
| 01/22/2004 | WO2003050289A3 Method for detecting microorganisms |
| 01/22/2004 | WO2003050248A3 Adenine nucleotide-binding protein-directed probes and methods of their synthesis and use |
| 01/22/2004 | WO2003037257A3 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 |
| 01/22/2004 | WO2003035909A3 A method for detecting disease using a fluidic device |
| 01/22/2004 | WO2003035229A3 Integrated fluidic device for sample preparation and assay |
| 01/22/2004 | WO2003029479A3 Sensitive and rapid detection of pathogenic organisms and toxins using fluorescent polymeric lipids |
| 01/22/2004 | WO2003020962A3 Method of identifying glycosyl transferase binding compounds |
| 01/22/2004 | WO2003020889A3 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules |
| 01/22/2004 | WO2003019195A3 Cellular immunity test with peptides fixed on a solid support |
| 01/22/2004 | WO2003018838A3 Interaction detection on several probe arrays |
| 01/22/2004 | WO2003014386A3 Method for identifying macrocyclic polyketides |
| 01/22/2004 | WO2003014380A3 Microoroganisms and cells for diagnosis and therapy of tumors |
| 01/22/2004 | WO2003004701A3 Method for determining the capacity of fusarium in producing trichothecene toxins |
| 01/22/2004 | WO2003004697A3 Method for detecting mutagenic substances |
| 01/22/2004 | WO2002078643A3 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 01/22/2004 | WO2002070729A3 Improved skin substitutes and uses thereof |
| 01/22/2004 | US20040016025 Rice promoters for regulation of plant expression |
| 01/22/2004 | US20040016006 Chromosome 3p21.3 genes are tumor suppressors |
| 01/22/2004 | US20040015021 Lubricant compositions containing ester-substituted hindered phenol antioxidants |
| 01/22/2004 | US20040014955 Identification of essential genes of cryptococcus neoformans and methods of use |
| 01/22/2004 | US20040014954 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 01/22/2004 | US20040014779 Testing for immunology response moderators; viricides, antitumor agents |
| 01/22/2004 | US20040014707 Method for inhibiting the toxicity of Bacillus anthracis |
| 01/22/2004 | US20040014706 Using protein antagonist; therapy for congestive heart failure; blocking gene expression |
| 01/22/2004 | US20040014702 Mammalian prostaglandin H synthase-2 |
| 01/22/2004 | US20040014701 Inhibiting retrotransposon and retroviral integration by targeting the atm pathway |
| 01/22/2004 | US20040014668 Human NK3-related prostate specific gene 1 |
| 01/22/2004 | US20040014666 Isolated human enzyme, nucleic acid molecules encoding human enzyme, and uses thereof |
| 01/22/2004 | US20040014649 Antiallergens, vision defects, skin disorders, asthma therapy |
| 01/22/2004 | US20040014636 Pharmaceutical compositions comprising a modulator of adamts-1 |
| 01/22/2004 | US20040014635 Anticancer agents |
| 01/22/2004 | US20040014241 Using microarrays to detect, monitor and screen biological activites of immobilized target proteins and peptides; colorimetric analysis |
| 01/22/2004 | US20040014231 System and method |
| 01/22/2004 | US20040014222 Automated immunohistochemical and in situ hybridization assay formulations |
| 01/22/2004 | US20040014220 Using electroporation to transfer nucleotide sequences and biologicaly active molecules into peripheral human blood cells; gene therapy |
| 01/22/2004 | US20040014219 Comprises expression vector coding fusion protein associated cell proliferation and/or differentiation; gene therapy; animal model for disease |
| 01/22/2004 | US20040014216 Using internal ribosome entry sites (IRES) to identifying and characterizing transcriptionally active regions in plants; tissue engineering; transgenic seeds |
| 01/22/2004 | US20040014208 Methods for culturing human lung mast cells and uses thereof |
| 01/22/2004 | US20040014201 Biosensor microarray for detecting hybridized DNA; genetic analysis; disease prevention and detection; genetic analysis |
| 01/22/2004 | US20040014200 Method for chemiluminescent detection |
| 01/22/2004 | US20040014190 Stable plasminogen activator inhibitor for treatment of thrombosis and cardiovascular diseases |
| 01/22/2004 | US20040014176 Comprises tumor necrosis factor receptor (DCR3) polypeptide for detection, diagnosis and treatment of cancer |
| 01/22/2004 | US20040014174 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 01/22/2004 | US20040014172 Comprises retroviral polypeptide for generating genetic vaccine for preventing viral infections; viricides; gene expression inhibition |
| 01/22/2004 | US20040014163 Immunoassay mixture for measuring calcium-dependent glutamate dehydrogenase activities and treating bone, teeth and oral diseases |
| 01/22/2004 | US20040014162 Regulating levels of tyrosine phosphatase activity of protein tyrosine phosphatase zeta/receptor-like protein (RPTP beta/zeta) in cells and/or tissues; antitumor agents; angiogensis inhibitors |
| 01/22/2004 | US20040014161 Method comprises selecting buffer and indicator conditions such that both have same affinity for protons such that relative amount of buffer protonated is proportional to amount of indicator protonated as pH of reaction mixture shifts |
| 01/22/2004 | US20040014160 For high throughput inhibition screening assays; involving metabolism based drug interactions which are a result of inhibition of cytochrome P450 enzymes |
| 01/22/2004 | US20040014159 Methods and kits for transferases |
| 01/22/2004 | US20040014144 Method of screening for substances acting on MSK1 |
| 01/22/2004 | US20040014140 Methods for identifying allosteric sites |
| 01/22/2004 | US20040014138 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor |
| 01/22/2004 | US20040014134 Two coloured fluorimetric protease assay |
| 01/22/2004 | US20040014133 Biotin-peg-substrate for a lipase assay |
| 01/22/2004 | US20040014131 Assay methods |
| 01/22/2004 | US20040014129 Amplification primer pairs and use thereof |
| 01/22/2004 | US20040014128 Comprises nucleotide sequences coding green fluorescent proteins derivative for use as diagnostic tools genetic engineering |
| 01/22/2004 | US20040014127 Compositions and methods for the detection of human T cell receptor variable family gene expression |
| 01/22/2004 | US20040014124 RMultiple specimens having different properties and origins, are bound onto matrix substrates, and oligonucleotides, proteins and drugs are spotted on each matrix in an array to examine those specimens at a time for multiple items |
| 01/22/2004 | US20040014122 Systematic identification of sporulation genes in spore forming bacteria comprising amplifying a portion of a gene from total cellular DNA of said spore forming bacteria by using a primer; and detecting the presence of the product |
| 01/22/2004 | US20040014119 Method of detecting nucleic acids |
| 01/22/2004 | US20040014118 Methods to detect Group A Streptococcus (GAS) in biological samples using real-time polymerase chain reaction (PCR); Primers and probes for the detection of GAS |
| 01/22/2004 | US20040014117 Includes an amplification device which permits the amplification of polynucleotides and an analysis device which quantifies the amount of the amplified polynucleotide products; automated apparatus |
| 01/22/2004 | US20040014115 Breast cancer susceptibility gene 1 (BRCA1), a tumor suppressor gene; the large deletions predispose the patients to breast cancer and ovarian cancer; methods for detecting the genetic variants used in detecting a predisposition to cancer |
| 01/22/2004 | US20040014114 Method for evaluating a tissue or biopsy sample to determine if the sample is early-stage melanoma |
| 01/22/2004 | US20040014113 Method for efficient RNA interference in mammalian cells |
| 01/22/2004 | US20040014111 Methods for the identification of IKKalpha function and other genes useful for treatment of imflammatory diseases |
| 01/22/2004 | US20040014110 Dendritic enriched secreted lymphocyte activation molecule |
| 01/22/2004 | US20040014109 Screening a subject for Alzheimer's disease and/or Parkinson's disease comprising detecting the presence or absence of a marker or functional polymorphism associated with a gene linked to these diseases |
| 01/22/2004 | US20040014107 RNP immunoprecipitation assay |
| 01/22/2004 | US20040014106 Electrical detection of DNA hybridization and specific binding events |
| 01/22/2004 | US20040014105 Methods for the enrichment of low-abundance polynucleotides |
| 01/22/2004 | US20040014104 Methods for disease detection |
| 01/22/2004 | US20040014101 Separating and/or identifying polymorphic nucleic acids using universal bases |
| 01/22/2004 | US20040014099 Susceptibility gene for human stroke; methods of treatment |
| 01/22/2004 | US20040014097 Systems, apparatus, and methods to simplify and improve genetic testing, analysis, and consultation |
| 01/22/2004 | US20040014095 Targets, methods, and reagents for diagnosis and treatment of schizophrenia |
| 01/22/2004 | US20040014091 Integrated system for high throughput capture of genetic diversity |
| 01/22/2004 | US20040014090 Encoded self-assembling chemical libraries (ESACHEL) |
| 01/22/2004 | US20040014088 Oligonucleotide sequence formula for labeling oligonucleotide probes and proteins for in-situ analysis |
| 01/22/2004 | US20040014087 Culturing a cell under conditions suitable for expression of the diagnostic and therapeutic polypeptide, wherein the cell is transformed with genetic engineered polynucleotide, and recovering the polypeptide so expressed |
| 01/22/2004 | US20040014086 Regulome arrays |
| 01/22/2004 | US20040014083 Detection of heteroduplex polynucleotides using mutant nucleic acid repair enzymes with attenuated catalytic activity |
| 01/22/2004 | US20040014079 Detection of 5t4 rna in plasma and serum |
| 01/22/2004 | US20040014078 Compositions and methods for rolling circle amplification |
| 01/22/2004 | US20040014076 Method for sequencing nucleic acid sequences without chain termination |
| 01/22/2004 | US20040014075 An isolated mammalian KIR 4.1 gene or a mammalian KIR 4.1 gene product as diagnostic marker for predicting susceptibility of an indivisual to having or developing a neurological disorder |
| 01/22/2004 | US20040014070 Use of silica material in an amplification reaction |
| 01/22/2004 | US20040014068 Solid medium and method for DNA storage |